Waters Corporation
Price: 363.18Company and Business Model
Waters Corporation specializes in analytical instruments and software for the life sciences, pharmaceutical, and chemical industries. Its core products include liquid chromatography and mass spectrometry systems, along with related consumables and services. Major business segments encompass Waters Division, which focuses on laboratory instruments, and TA Instruments, which provides thermal analysis and rheology solutions. The primary revenue sources are from instrument sales, consumables, and service contracts.
Investment Profile
The investment profile of Waters Corporation is more aligned with value investors, given its established market presence and focus on stable revenue streams. The company exhibits moderate growth potential, but with heightened risk factors that may deter conservative investors. This profile suggests a balanced approach for those considering long-term investment strategies.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- 7.88 OK
- Revenue QoQ — quarter-over-quarter revenue growth
- 35.9% ↑
- EPS surprise
- 16.9% better than expected
- 20d volatility
- 2.6% stable
Forecast impact
positiveTrack in portfolio
Price chart
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-11 05:37 | Buy | Hold | Mixed performance; high risk with uncertain momentum. |
| 2026-06-03 02:56 | Hold | Buy | Strong revenue growth, but recent price volatility concerns. |
| 2026-05-22 03:37 | Sell | Hold | Strong revenue growth, but mixed momentum signals. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-06-03 09:27 | HSBC | Target Raised | 415 → 435 | 371.93 |
| 2026-05-07 12:42 | Deutsche Bank | Target Raised | 330 → 350 | 351.33 |
| 2026-05-07 09:42 | Barclays | Target Raised | 400 → 425 | 349.53 |
Nothing yet